Mats Bengtsson
Overview
Explore the profile of Mats Bengtsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
587
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furian L, Heemann U, Bengtsson M, Bestard O, Binet I, Bohmig G, et al.
Transpl Int
. 2025 Jan;
37:13886.
PMID: 39867871
Highly sensitized (HS) patients in need of kidney transplantation (KTx) typically spend a longer time waiting for compatible kidneys, are unlikely to receive an organ offer, and are at increased...
2.
Miclescu A, Ronngren C, Bengtsson M, Gordh T, Hedin A
Pain
. 2023 Dec;
165(6):1404-1412.
PMID: 38147413
It is not known why some patients develop persistent pain after nerve trauma while others do not. Among multiple risk factors for the development of persistent posttrauma and postsurgical pain,...
3.
Duus Weinreich I, Andersson T, Birna Andresdottir M, Bengtsson M, Biglarnia A, Bistrup C, et al.
Transplant Direct
. 2023 Oct;
9(11):e1549.
PMID: 37854025
Background: Kidney transplant candidates may be incompatible with their intended living donors because of the presence of antibodies against HLA and/or ABO. To increase the possibility of finding an acceptable...
4.
Hellstrom V, Tufveson G, Loskog A, Bengtsson M, Enblad G, Lorant T
PLoS One
. 2022 Sep;
17(9):e0271293.
PMID: 36129920
Background: Malignancies in the urinary tract and the kidney graft are quite common after kidney transplantation. In some selected cases tumours develop from donor-derived tissue. Objectives: We hypothesised that there...
5.
Weinreich I, Bengtsson M, Lauronen J, Naper C, Lokk K, Helantera I, et al.
Am J Transplant
. 2022 Aug;
22(12):2869-2879.
PMID: 36030513
In March 2009, the Scandiatransplant acceptable mismatch program (STAMP) was introduced as a strategy toward improving kidney allocation to highly sensitized patients. Patients with a transplantability score ≤ 2% are...
6.
Ruggeri A, de Wreede L, Muller C, Crivello P, Bonneville E, Petersdorf E, et al.
Haematologica
. 2022 May;
108(2):645-652.
PMID: 35546480
No abstract available.
7.
Petersdorf E, Bengtsson M, Horowitz M, McKallor C, Spellman S, Spierings E, et al.
Blood
. 2022 Mar;
139(20):3009-3017.
PMID: 35271697
HLA-DQ heterodimers increase the susceptibility to autoimmune diseases, but their role in hematopoietic cell transplantation is unknown. We tested the hypothesis that outcome after HLA-matched and HLA-DQ-mismatched hematopoietic cell transplantation...
8.
Creary L, Gangavarapu S, Caillier S, Cavalcante P, Frangiamore R, Lie B, et al.
Front Immunol
. 2021 Jun;
12:667336.
PMID: 34163474
Genetic susceptibility to myasthenia gravis (MG) associates with specific HLA alleles and haplotypes at the class I and II regions in various populations. Previous studies have only examined alleles at...
9.
Jordan S, Legendre C, Desai N, Lorant T, Bengtsson M, Lonze B, et al.
Transplantation
. 2020 Oct;
105(8):1808-1817.
PMID: 33093408
Background: Highly HLA sensitized patients have limited access to life-saving kidney transplantation because of a paucity of immunologically suitable donors. Imlifidase is a cysteine protease that cleaves IgG leading to...
10.
Petersdorf E, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, et al.
Blood
. 2020 Jun;
136(3):362-369.
PMID: 32483623
Hematopoietic cell transplantation (HCT) from HLA-mismatched unrelated donors can cure life-threatening blood disorders, but its success is limited by graft-versus-host disease (GVHD). HLA-B leaders encode methionine (M) or threonine (T)...